SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is trending after its latest earnings report showed record revenue, gross margin, and a return to profitability, prompting excitement about a potential turnaround. The community is actively discussing the company's strong security growth and the increasing tailwinds from AI adoption, with many anticipating further upside for the edge computing provider.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot ($HUBS) is trending after its latest financial results, which, despite exceeding expectations and including a significant share repurchase program, led to a sharp stock decline. This has ignited intense community debate, with many bulls arguing the stock is deeply oversold and fundamentals are strong, while bears double down on the "Death By AI" narrative, fearing broad AI disruption for the SaaS sector.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending after its Optune Pax therapy received FDA approval for locally advanced pancreatic cancer, marking the first new treatment in nearly three decades; however, community sentiment is split between enthusiasm for this breakthrough and skepticism regarding the modest survival extension.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing high activity as its "Eagle Line" pilot facility begins shipping B-samples to various OEMs, marking a significant step toward solid-state battery commercialization. The community is split, with bulls excited by this progress and skeptics frustrated by the ongoing absence of specific customer or revenue details, fueling debate around its market trajectory.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is experiencing a significant sell-off following its earnings report, where a beat on Q4 results was overshadowed by weaker-than-expected Q1 guidance. This has ignited a fierce debate within the community, with many investors calling the drastic drop an overreaction and a buying opportunity, while others remain bearish due to persistent losses and looming AI competition.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X is trending as investors anticipate its upcoming SPAC merger vote and NYSE debut as Infleqtion, driven by recent news of major contracts with NASA for a quantum gravity sensor mission and the U.S. Department of Energy for energy grid optimization. The community is actively discussing its potential as a leading, undervalued quantum technology play with real-world applications, despite some historical concerns about SPAC volatility.

Beta Technologies, Inc. engages in the designing, manufacturing and sell electric aircraft, electric propulsion systems, charging systems and components. It focuses on the enabling technologies essential to electric aviation, including batteries, motors, flight control systems and a nationwide network of electric charging and related equipment. The company was founded by Kyle B. Clark in 2017 and is headquartered in South Burlington, VT.

BETA Technologies Inc - Ordinary Shares - Class A

BETA Technologies is seeing heightened interest after a major e-commerce company disclosed a significant stake, alongside multiple analyst upgrades citing upcoming certification milestones and strategic partnerships. The community is actively debating the company's potential in the evolving eVTOL market, comparing its trajectory against industry peers.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending following its recent announcement to advance its oral obesity drug directly to Phase 3 with FDA validation, significantly accelerating its timeline within the rapidly expanding GLP-1 market. Community discussion reflects strong conviction in the company's undervalued pipeline and potential for a strategic partnership or acquisition, further bolstered by recent regulatory action against compounded alternatives.

Roundhill ETF Trust - Roundhill Innovation-100 0DTE Covered Call Strategy ETF

Roundhill Innovation-100 0DTE Covered Call Strat ETF

Roundhill Innovation-100 0DTE Covered Call Strat ETF (QDTE) is trending as investors debate its recent string of lower weekly distributions and persistent NAV erosion, with many questioning the fund's long-term sustainability and total return performance compared to its underlying index.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

Ghost Crypto is generating significant community excitement as the privacy layer of Solana, driven by anticipation for upcoming features like GhostSend and a structured ecosystem participation model poised to deliver revenue sharing to holders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ovid Therapeutics $OVID Position Cut by TLS Advisors LLC

TLS Advisors LLC lowered its holdings in shares of Ovid Therapeutics (NASDAQ:OVID - Free Report) by 97.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and...

Ovid Therapeutics (NASDAQ:OVID) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen lowered Ovid Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Wall Street Zen Upgrades Ovid Therapeutics (NASDAQ:OVID) to "Hold"

Wall Street Zen upgraded Ovid Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

FY2025 Earnings Forecast for OVID Issued By Lifesci Capital

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Equities researchers at Lifesci Capital issued their FY2025 earnings estimates for Ovid Therapeutics in a research report issued on Monday, December...

Ovid Therapeutics (NASDAQ:OVID) Earns Outperform Rating from Analysts at Lifesci Capital

Lifesci Capital assumed coverage on shares of Ovid Therapeutics in a research report on Monday. They set an "outperform" rating and a $4.00 price objective for the company...

Ovid Therapeutics' (OVID) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright restated a "buy" rating and issued a $2.00 price objective on shares of Ovid Therapeutics in a research report on Monday...

Ovid Therapeutics (NASDAQ:OVID) Upgraded at Roth Capital

Roth Capital raised shares of Ovid Therapeutics to a "strong-buy" rating in a research note on Thursday...

Ovid Therapeutics Names Petra Kaufmann Chief Medical Officer

(RTTNews) - Ovid Therapeutics Inc. (OVID) on Tuesday announced the appointment of Petra Kaufmann as its chief medical officer...

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Ovid Therapeutics (NASDAQ:OVID - Get Free Report) have been given a consensus rating of "Buy" by the nine analysts that are presently covering the stock, Marketbeat reports. One analyst has...

William Blair Issues Pessimistic Forecast for OVID Earnings

Ovid Therapeutics (NASDAQ:OVID - Free Report) - Stock analysts at William Blair cut their FY2025 EPS estimates for Ovid Therapeutics in a research note issued to investors on Wednesday, November...

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.

Ovid Therapeutics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

Current Price	$1.59
Prev Close	$1.64
Open	$1.66
Dividend Yield	0.00%
50-Day Moving Average	$1.63
Beta	1.18
Avg. Volume	1.62M
PE Ratio	-3.21

52-Week High	$2.01
52-Week Low	$0.2425
Market Capitalization	$213.5M
EPS (Annual)	-$0.3728
Price to Book	2.61
Revenue Per Employee	$24,608.70

OVID
Ovid Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OVID News

OVIDOvid Therapeutics Inc